RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -66.96% | -38.45% | 23.97% | 38.67% | 47.54% |
| Total Depreciation and Amortization | -17.70% | -52.36% | -48.47% | -58.12% | -50.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -42.86% | -- |
| Total Other Non-Cash Items | -15,715.38% | 75.36% | -1,641.25% | -44.11% | 95.49% |
| Change in Net Operating Assets | 1,319.80% | -432.04% | 29.57% | 16.75% | 144.93% |
| Cash from Operations | 142.63% | -105.91% | -32.15% | 86.41% | 79.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -211.44% | -87.99% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -211.44% | -88.36% | 2,348.86% | 1,384.76% | 349.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 64.88% | 70.32% | 80.07% | 70.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 71.95% | -- | -- | -101.63% | 2.38% |
| Cash from Financing | 24.59% | 63.64% | 69.53% | 71.65% | 62.35% |
| Foreign Exchange rate Adjustments | 107.14% | 119.25% | -183.96% | -38.89% | -158.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.60% | -438.84% | 155.75% | 138.89% | 82.62% |